Are new technologies always reducing patient doses in cardiac procedures?

Area of Science:

• Medical Imaging
• Cardiovascular Technology
• Radiological Physics

Background:

• Dynamic digital flat-panel (FD) imaging technology presents advantages in sensitivity and image quality over traditional image intensifier (II) technology.
• Interventional cardiology procedures increasingly utilize advanced imaging systems, necessitating a comparison of their performance and patient dose implications.

Purpose of the Study:

• To compare the system performance and patient dose impact of image intensifier (II) versus flat-panel digital detector (FD) angiography systems in interventional cardiology.
• To evaluate if reduced entrance dose rates from FD systems correlate with decreased overall patient dose during procedures.

Main Methods:

• Comparative study of II and FD angiography systems in interventional cardiology.
• Measurement of entrance surface air kerma rates, fluoroscopy time (FT), and dose-area product (DAP).
• Analysis of data for coronary angiography (CA) and percutaneous transluminal coronary angiography (PTCA).

Main Results:

• FD systems demonstrated reduced entrance dose rates by up to 40% compared to II systems.
• For coronary angiography, fluoroscopy time and dose-area product were comparable between II and FD systems (FT: 4.3 vs 4.4 min; DAP: 31.2 vs 33.4 Gy cm2).
• For percutaneous transluminal coronary angiography, fluoroscopy time was similar (11.4 vs 10.7 min), but dose-area product was higher with the FD system (52.1 vs 66.9 Gy cm2).

Conclusions:

• While FD systems can achieve lower entrance dose rates, this does not automatically guarantee a reduction in overall patient dose in clinical interventional cardiology settings.
• Procedure complexity and specific application (e.g., PTCA) influence the final patient dose, irrespective of the detector technology's inherent dose rate capabilities.
• Further research is needed to optimize imaging protocols for FD systems to fully leverage their potential for dose reduction in complex cardiovascular interventions.